Company CVAbout Krebs Biochemicals & Industries Ltd 
Krebs Biochemicals & Industries Ltd
Micro Cap
Pharmaceuticals & Drugs
Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
Company Coordinates
Company Details
Kothapalli(V) Kasimkota(M), Anakapalli Vishakapatnam Andhra Pradesh : 531031
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 19.62 Cr
Number of Shares
1.96 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
20-May-2020
1.96
19.62
1620000
10
Conversion of Warrants
05-Feb-2020
1.8
18.00
1370000
10
Preferential Allotment
31-Jan-2019
1.66
16.63
2886300
10
Right Issues
28-May-2016
1.37
13.74
680000
10
Conversion of Warrants
03-Oct-2015
1.31
13.06
650000
10
Conversion of Warrants
03-Oct-2015
1.31
13.06
650000
10
Conversion of Warrants
09-May-2015
1.18
11.81
2300000
10
Allotment of Equity To Others
09-May-2015
1.24
12.41
600000
10
Allotment of Equity To Others
09-May-2015
1.18
11.81
2300000
10
Allotment of Equity To Others
09-May-2015
1.24
12.41
600000
10
Allotment of Equity To Others
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 5 FIIs (0.5%)
Promoter with highest holding
Ipca Laboratories Limited (49.65%)
Highest Public shareholder
Sun Pharmaceutical Industries Ltd (4.81%)
Individual Investors Holdings
20.42%
Board of Directors
Management
Designation
Remuneration
G V L Prasad
Independent Director
90.0 k
R T Ravi
Chairman (Non-Executive)
45.0 k
Avinash Ravi
Non Executive Director
45.0 k
Tangirala Malati
Independent Director
65.0 k
Satish Khivsara
Independent Director
90.0 k
Raj Kamal Prasad Verma
Independent Director
40.0 k
Rohit Taparia
Company Sec. & Compli. Officer
0
Jitendra Shah
Managing Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Income - Fee for Providing Manufacturing Services
0.31
0.64%
Other Operating Income - Fee for Providing Manufacturing Services
Other Operating Income - Fee for Providing Manufacturing Services
Stock DNARevenue and Profits:
Net Sales:
11 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-8 Cr
Pharmaceuticals & Drugs
INR 159 Cr (Micro Cap)
NA (Loss Making)
27
0.00%
-1.57
18.84%
-1.18
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
